About: Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1988

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1988 (uk) artículu científicu espublizáu en xineru de 1988 (ast) im Jahr 1988 veröffentlichter wissenschaftlicher Artikel (de) artikull shkencor i botuar më 01 janar 1988 (sq) scientific article published on 01 January 1988 (en)
publication date	wds:Q68125129-7F608D45-29A9-4EB8-B940-9CB1DBF35C48
publication date	1988-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q68125129-C796F831-E850-4539-95C1-D09EFED351B0
language of work or name	English
cites work	wds:Q68125129-02E7379B-EB92-45DE-AB77-F5E8697ED82A wds:Q68125129-52A3B59F-A4BF-44B2-B6E7-BAA81B9C5C98 wds:Q68125129-5430F947-1887-485E-A3FD-65B049EFF387 wds:Q68125129-63B8D8E5-2126-4C65-B526-0F99D2468AA2 wds:Q68125129-81BF1A13-66C8-4FC6-B976-2E199F8A22BC wds:Q68125129-822ECFCB-DE6C-4FB5-8783-3B0143DB70BE wds:Q68125129-840AC97B-CABA-4F47-9789-C899A37AE8DB wds:Q68125129-9CC8EDEC-F6A0-49DA-85FE-95513B9AF771 wds:Q68125129-A5E09F9D-B6E5-4B28-B4BA-AB65ACCA9F75 wds:Q68125129-B4C2C612-F342-4817-9FC6-A078ADA036F3 wds:Q68125129-B5B8ECCD-DFF0-46D8-928B-4B11FB6EF6E3 wds:Q68125129-D1C37424-FDFE-4BB5-A317-FB0CD6DE46AB wds:Q68125129-EA8E2132-787C-4695-9E58-C722FEF3F5C4 wds:Q68125129-EC881C50-E860-4D6C-8B77-257984874E9F
cites work	Prophylactic portacaval anastomosis Prophylactic endoscopic sclerosing treatment of the esophageal wall in varices -- a prospective controlled randomized trial Transection of the oesophagus for bleeding oesophageal varices Tables of the number of patients required in clinical trials using the logrank test. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples A randomized controlled study of propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a final report Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study Prediction of variceal hemorrhage by esophageal endoscopy Prophylactic portal nondecompression surgery in patients with esophageal varices. An interim report Prophylactic endoscopic sclerotherapy of oesophageal varices. A prospective controlled study Redistribution of cardiac output to the kidneys during oral nadolol administration beta-Adrenoceptor-blocking agents and the kidney: effect of nadolol and propranolol on the renal circulation The natural history of esophageal varices; a study of 115 cirrhotic patients in whom varices were diagnosed prior to bleeding Effects of nadolol treatment on renal and hepatic hemodynamics and function in cirrhotic patients with portal hypertension
author name string	wds:Q68125129-1F268740-3367-43FA-B2F9-4FFFC2921848 wds:Q68125129-26C87FDE-6D0D-4023-95E0-4D222AFFC6BD wds:Q68125129-93A4D191-C4A3-4831-8EBC-D7EB92C89502 wds:Q68125129-A4812FF8-9A79-40B5-A1C3-A4497CC20E6B
author name string	G Bellati G Idéo E Fesce D Grimoldi
rdfs:label	Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (en) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (nl) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (sq)
skos:prefLabel	Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (en) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (nl) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (sq)
name	Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (en) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (nl) Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (sq)
title	wds:Q68125129-CF1E1E84-4B79-4EE5-B229-833131EB4D34
title	Nadolol can prevent the first gastrointestinal bleeding in cirrhotics: a prospective, randomized study (en)
page(s)	wds:Q68125129-87A4C3F1-F8BF-4552-8C63-BE5321DD4D16
page(s)	6-9
instance of	wds:Q68125129-093AD43D-09E5-482F-A500-01E658B67F34
instance of	scholarly article
PubMed ID	wds:Q68125129-733C6253-6ACF-49E3-887F-ED83C735944C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/3276591
PubMed ID	3276591
published in	wds:Q68125129-F3DE028A-2E27-446D-8B76-1987C6CA0A0D
published in	Hepatology
issue	wds:Q68125129-F9B564B8-FCF4-4475-B667-7EA71BEB2010
volume	wds:Q68125129-C8678CFB-BFEF-4A0D-B51B-BB09CD515BE2
issue	1
volume	8
DOI	wds:Q68125129-E0CB98B3-547F-45DE-92B2-66F57182280F
DOI	http://dx.doi.org/10.1002/HEP.1840080103
DOI	10.1002/HEP.1840080103
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q68125129
is cites work of	Natural history of portal hypertension in patients with cirrhosis Cost-effectiveness analysis of variceal ligation vs. beta-blockers for primary prevention of variceal bleeding Banding ligation versus beta-blockers for primary prevention in oesophageal varices in adults Incidence of large oesophageal varices in patients with cirrhosis: application to prophylaxis of first bleeding. UK guidelines on the management of variceal haemorrhage in cirrhotic patients. British Society of Gastroenterology U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. A prospective study of the ability of three endoscopic classifications to predict hemorrhage from esophageal varices Enhancement of portal pressure reduction by the association of isosorbide-5-mononitrate to propranolol administration in patients with cirrhosis. Portal hypertension Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension A hepatologist's view of variceal bleeding Propranolol in the prevention of the first hemorrhage from esophagogastric varices: A multicenter, randomized clinical trial. The Boston-New Haven-Barcelona Portal Hypertension Study Group Current management of portal hypertension Esophageal varices. I. Clinical presentation, medical therapy, and endoscopic therapy Morbidity and mortality of portal hypertension. Improving prognosis following a first variceal haemorrhage over four decades Evidence-based clinical practice guidelines for liver cirrhosis 2015. Prophylactic propranolol: the first big step Modern management of oesophageal varices Preventive therapy of first gastrointestinal bleeding in patients with cirrhosis: results of a controlled trial comparing propranolol, endoscopic sclerotherapy and placebo Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis Pharmacologic therapy of portal hypertension and variceal hemorrhage Long term management of oesophageal varices Why is prophylactic portal nondecompressive surgery effective in preventing hemorrhage from esophageal varices? The initial hemorrhage from esophageal varices

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software